The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category Health
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EDV | 71.85 | 0.51 | +0.71% |
| Vanguard Extended Duration Trs ETF | |||
| TPYP | 34.16 | -0.20 | -0.58% |
| Tortoise North American Pipeline | |||
| FJP | 51.06 | -0.35 | -0.68% |
| First Trust Japan AlphaDEX® ETF | |||
| FDCF | 39.10 | -0.30 | -0.77% |
| Fidelity Disruptive Communications ETF | |||
| CNCR | 12.66 | -0.15 | -1.20% |
| Range Cancer Therapeutics ETF | |||
A.I.dvisor indicates that over the last year, HGHTX has been closely correlated with FSPHX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if HGHTX jumps, then FSPHX could also see price increases.
| Ticker / NAME | Correlation To HGHTX | 1D Price Change % | ||
|---|---|---|---|---|
| HGHTX | 100% | -0.32% | ||
| FSPHX - HGHTX | 92% Closely correlated | -0.43% | ||
| VHCIX - HGHTX | 92% Closely correlated | -0.10% | ||
| SHSAX - HGHTX | 91% Closely correlated | N/A | ||
| JFNIX - HGHTX | 90% Closely correlated | +0.10% | ||
| JNGLX - HGHTX | 89% Closely correlated | +0.10% | ||
More | ||||